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mRNA abundance is buffered in human cells 
 
Abstract. Evidence from yeast and mammals argues the existence of cross-talk between 
transcription and mRNA decay. Stabilization of transcripts upon depletion of mRNA decay 
factors generally leads to no changes in mRNA abundance, attributing this to decreased 
transcription rates. We show that knockdown of human XRN1, CNOT6 and ETF1 genes in 
HepG2 cells led to significant alteration in stability of specific mRNAs, alterations in half-life 
were inversely-associated with transcription rates, mostly not resulting in changes in 
abundance. We demonstrate the existence of the gene expression buffering mechanism in 
human cells that responds to both transcript stabilization and destabilization to maintain mRNA 
abundance via altered transcription rates and may involve translation. We propose that this 
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Introduction. Maintenance of mRNA abundance is vital for regulation of eukaryotic gene 
expression. It has long been viewed that transcription in the nucleus and mRNA decay in the 
cytoplasm determine the steady-state mRNA level as independent processes by merely 
supplying and degrading transcripts in their respective compartments. Over the last decade, 
pioneering work in yeast and mammals has revealed that these two processes, which are 
separated spatially and temporally are tightly coupled and can communicate with each other 
(1,2). More specifically, the steady-state level of mRNA is highly resistant to perturbations in 
decay rate, as the rate of transcription can be adjusted to maintain the mRNA steady-state 
level. The mRNA decay machinery has been shown to play a direct role in buffering the 
abundance of transcripts by regulating its levels via coordinating both degradation of mRNA 
and the rate of transcription (1).  
In S. cerevisiae, the fate of mRNA in the cytoplasm has been shown to be pre-determined in 
the nucleus (1). Growing lines of evidence strongly suggest that the fate of the mRNA in the 
cytoplasm can be determined in a promoter-dependent manner (3,5,6). Promoter sequences 
influence the loading of nascent mRNA with markers (3). These markers could be proteins 
that contribute to the mRNP formation (e.g. a protein kinase Dbf2p) or potentially non-coding 
RNAs. It has been demonstrated that switching the promoter sequence of the highly turned 
over RPL30 transcript with the ACT1 promoter stabilises RPL30 mRNA (4). Similarly, 
switching the promoter sequences of CWL2 and SWI5 genes with the ACT1 promoter 
prevented cell-cycle progression-mediated decay, stabilising the transcript, and this was 
attributed to changes in mRNP formation (5). Dbf2p (functionally associated with the 
CCR4/Not complex, the conserved eukaryotic deadenylase complex) was shown to be 
imprinted onto CLW2 and SWI5 transcripts in a promoter-dependent manner to promote rapid 
mRNA decay upon cell cycle progression, suggesting a promoter-dependent formation of the 
nascent mRNP (5). Furthermore, RNA Pol II subunits have been shown to influence events 
downstream of transcription. The dimeric RNA Pol II Rpb4/7 sub-complex is imprinted onto a 
specific range of yeast mRNAs in a RNA Poll II-dependent manner (6). Rpb4/7 co-
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transcriptionally binds to the nascent transcript and remains bound through nuclear export (7) 
and subsequently regulates translation (8), localisation (9) and decay in the cytoplasm (10). It 
was shown that cytoplasmic functions of Rpb4 were dependent on Not5, a subunit of the Ccr4-
Not complex (11). Collectively these data argue the existence of tight coupling between 
transcription, translation and decay of mRNA in yeast.  
Stabilization of mRNAs in the cytoplasm can in turn influence transcription events in the 
nucleus. The 5’-3’ mRNA decay pathway appears to degrade the majority of yeast mRNAs, 
with deletion or inactivation of exonucleolytic activity of XRN1 (eXoRiboNuclease 1) resulted 
in globally reduced decay rates (1). Stabilization of mRNA did not affect its total abundance 
as the rate of transcription was reduced which resulted in maintenance of steady-state mRNA 
levels (1,12,13). It was found that cytoplasmic 5’-3’ decay factors can be localized to the 
nucleus in an XRN1-dependent manner and XRN1 can bind to transcription start sites 
promoting initiation and elongation of transcription. Similarly, knockdown of PARN (the 
mammalian PolyA specific RiboNuclease) in mouse myoblasts, a subset of transcripts was 
stabilized while their rate of transcription was downregulated, resulting in either no changes 
or a small decrease in transcript steady-state levels (14). Consistently, deletion of components 
of the Ccr4-Not complex in yeast did not lead to significant changes in abundance of 
transcripts, as stabilization of mRNAs was met with inverse changes to the rate of transcription 
(15). Together these data suggest that both 5’-3’ and 3’-5’ mRNA decay factors may signal 
changes in transcript stability in the cytoplasm back to the nucleus leading to alterations in 
transcription rates. This is consistent with transcription and mRNA decay in yeast and 
mammals coordinating activities of the opposing process across the nuclear membrane to 
maintain steady-state mRNA levels in the cytoplasm. However, whether this buffering 
mechanism maintains the abundance of mRNA in human cells and involves translational 
factors is still unknown.  
In this study we tested the existence of an mRNA steady-state buffering mechanism in human 
liver carcinoma HepG2 cells in response to shRNA-mediated knockdown (KD) of the 5’-3’ 
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exonuclease XRN1, the general deadenylase and human Ccr4 homologue CNOT6 and the 
translation release factor 1, ETF1. We found that XRN1-mediated buffering maintains the 
steady-state abundance of specific mRNAs via coordination of degradation and transcription 
in human cells and propose that this is a conserved eukaryotic feature. Upon CNOT6 
knockdown-mediated destabilization of mRNA, steady-state levels can be maintained, and we 
attribute this to an increased rate of transcription. The translational machinery can also play a 
role in preserving abundance of specific mRNAs, or a subset of transcripts, albeit with a lesser 
level of accuracy. The presented results reveal the existence of an inverse relationship 
between stability and transcription, a compensatory mechanism in human cells which 
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Results 
shRNA knockdowns. shRNA constructs with the pLKO.1 backbone were packaged into 
lentiviral particles and used to knockdown XRN1, CNOT6 and ETF1 genes in the human 
hepatocellular carcinoma HepG2 cell-line. A control cell-line was generated by transduction 
with a scrambled target sequence. Knockdown of XRN1, CNOT6 and ETF1 gene expression 
in the human hepatocellular-carcinoma HepG2 cell-line was confirmed at the level of both 
mRNA and protein (Fig. 1A and 1B for XRN1; Fig. 2A and 2B for CNOT6 and Fig. 3A and 3B 
for ETF1).  
Perturbations to mRNA decay machinery do not always lead to mRNA stabilization in 
human HepG2 cells. Based on analysis in both S. cerevisiae and mice, stabilization of 
transcripts upon knockdown/knockout of RNA decay factors does not necessarily lead to a 
corresponding increase in the level of the respective mRNA (1,14-16). To test whether this is 
the case in human cells, ten genes related to different cellular functions, such as tumorigenesis 
(proto-oncogenes and apoptosis related genes), cell cycle as well as inflammatory factors and 
non-cancerous genes were randomly selected for this study. The transcript half-life was 
determined by monitoring the change in transcript abundance, after inhibition of transcription 
with actinomycin D, over a time course of two hours.  A comparison was made between the 
HepG2 control cells and two knockdown derivatives; XRN1-KD and CNOT6-KD (Table 1). As 
expected, enhanced stability of mRNA was observed for eight transcripts in XRN1-KD cell-
lines, whilst stability of the IL1A transcript was unchanged and stability of the CDK6 mRNA 
was decreased (Table 1; Fig. 1C). Surprisingly, knockdown of CNOT6 extended the half-life 
of only FOS and ZFP36 mRNAs, whilst the stability of the c-MYC, BAX, and AIMP2 transcripts 
was not altered but CDKN1A, IL1A, STX5, CPLX2 and CDK6 transcripts were all destabilized 
(Table 1; Fig 2C). From these data, we concluded that XRN1 plays a major role in the 
degradation of most transcripts in human HepG2 cells whilst the loss of CNOT6 increased the 
production of specific pre-mRNA (Fig. 2E) in response to enhanced degradation of respective 
transcripts (Fig. 2C). 
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Xrn1-mediated buffering exists in HepG2 cells. It has been shown that Xrn1 plays a key 
role in buffering the abundance of transcripts in S. cerevisiae. We found that six transcripts 
with enhanced stability in the XRN1-KD cell-line, FOS, c-MYC, BAX, CDKN1A, STX5 and 
CPLX2 (Fig. 1C) also showed reduced transcription rates, based on the accumulation of pulse-
labelled unspliced transcript (pre-mRNA) (Fig. 1E).  For these transcripts, mRNA abundance 
was not significantly altered with the exception of CPLX2, which had an enhanced steady-
state level (Fig. 1D). Interestingly, the ZFP36 and AIMP2 transcripts showed both stabilization 
(Fig. 1C) and enhanced transcription (Fig. 1E) and, hence increased steady-state levels in the 
XRN1-KD cell-line (Fig. 1D), this suggests that not all transcripts are under the regulation of 
XRN1-mediated buffering. For the CDK6 transcript, knockdown of XRN1 led to destabilisation, 
a lower rate of transcription and decreased mRNA abundance (Fig. 1C, D and E). From these 
data we conclude that abundance of most transcripts tested in this study is regulated in an 
XRN1-dependent manner. 
mRNA buffering mechanism responds to CNOT6-dependent mRNA destabilization. As 
previously stated, we tested the effect of CNOT6 knockdown on transcript half-life. 
Surprisingly, we observed destabilization CDKN1A, IL1A, STX5, CPLX2 and CDK6 transcripts 
(Fig. 2C) and this was associated with enhanced transcription (Fig. 2E). The steady-state level 
of IL1A, STX5 and CPLX2 transcripts in CNOT6-KD was maintained and the abundance of 
CDKN1A transcript increased (Fig. 2D). This supports the existence of a buffering mechanism, 
which can be triggered in response to CNOT6-KD and resembles the previous observation in 
mice that steady state levels are not always accurately maintained (14). Like the XRN1 
knockdown phenotype, the CDK6 transcript was destabilized and had a lower transcription 
rate, as well as lower abundance (Fig 2C, D and E). Only FOS and ZFP36 mRNAs showed a 
significant increase in stability and mirrored the transcription and abundance phenotypes of 
ZFP36 and AIMP2 transcripts in XRN1-KD, with both enhanced transcription rates and steady-
state levels being observed (Fig. 2C, D and E). We concluded that mRNA-buffering is active, 
and responsive, to both enhanced degradation and stabilization by inversely altering 
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transcription rates, such that the level of specific mRNA can be maintained by multiple factors, 
or via a pathway-specific mechanism.  
Knockdown of translation termination factor 1 triggers a buffering response.  The 
current data suggest the existence of crosstalk between transcription, stability and translation 
(8). However, whether translation or its factors play a role in the maintenance of mRNA steady-
state levels is not yet known. Hence, we decided to test the involvement of a member of the 
translational apparatus in this buffering response and investigated mRNA stability, 
transcription and abundance in response to ETF1-KD (eRF1 in yeast), that is responsible for 
recognition of the stop codon (Table 1; Fig. 3). Stability of four transcripts, BAX, CDKN1A, 
STX5 and CDK6 decreased while no changes in half-life were observed for FOS, c-MYC, 
CPLX2 and AIMP2 transcripts (Fig. 3C). Transcript stability of IL1A and ZFP36 increased in 
response to knockdown of ETF1 (Fig. 3C). These data suggest that translation may be 
interconnected with mRNA stability in human cells as previously shown in yeast (13, 28).   
ETF1 knockdown-mediated destabilization also triggers a buffering response as the rate of 
transcription of specific genes increased in ETF-1 KD cell-lines (Fig. 3E) resembling the 
CNOT6-KD phenotype. Like XRN1-KD and CNOT6-KD, stability and transcription of CDK6 
was decreased, suggesting that some transcripts are either exempt from buffering, or 
regulated in a pathway-specific manner. While the level of the BAX transcript was not 
changed, abundance of both CDKN1A and STX5 mRNAs was increased, suggesting the 
enhanced rate of transcription was not precisely coordinated in response to ETF1-KD (Fig. 
3E). The stabilized ZFP36 transcript also had an enhanced rated of transcription as well as 
overall level of abundance (Fig. 3E, D), whilst stabilization of IL1A correlated with an increase 
in transcription (Fig. 3C, E). We conclude that translation factors may be a part of the buffering 
mechanism, which adjusts the abundance of specific transcripts in response to changes in 
stability, via increased transcription rates. 
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Discussion 
We investigated the existence of a gene expression regulatory mechanism in human 
cells, namely the buffering mechanism which maintains the steady-state levels of mRNAs, in 
response to perturbation of the mRNA decay. We found in HepG2 cells, upon KD of XRN1, 
CNOT6 or ETF1, changes in stability of specific transcripts does not always lead to changes 
in the level of their abundance, this is attributed to inverse-changes in the rate of transcription. 
XRN1-KD mediated stabilization was coupled with a diminished rate of transcription and 
hence, resulted in minimal changes in abundance of several mRNAs consistent with previous 
findings in yeast and mammals (1,13,15,16). However, observed destabilization of specific 
transcripts in CNOT6-KD and ETF1-KD cells is coupled with enhanced rates of mRNA 
synthesis that can maintain the pre-KD steady-state level of mRNAs. Importantly, it appears 
that the expression of some genes is regulated by multiple decay or translation factors, whilst 
expression of other genes seems to be regulated in a decay-factor or pathway-specific 
manner. 
The level of mRNA is determined by the balance between transcription and mRNA decay (1). 
Traditionally, it has been the view that the main role of mRNA decay machinery in the 
cytoplasm was to act at the end of the mRNA life. It is now established that mRNA stability is 
integral to regulation of gene expression and is critical to the quick adaptive response upon 
changes in environmental signals (31). Furthermore, it was recently discovered that knockout 
or disruption of decay factors, such as Xrn1, Ccr4, Caf1 in yeast, and PARN in mice myoblasts, 
leads to transcript stabilization but does not result in changes in the total level of expression 
for many mRNAs as the rate of transcription was diminished (1,14,15). These data have 
revealed the existence of a cross talk between mRNA decay and transcription which is 
responsible for buffering mRNA abundances. We have shown that equivalent mechanisms 
exist in human cells, may involve translation and are likely to be conserved in eukaryotes. 
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The presented data shows that most transcripts tested (8 out of 10) in HepG2 cells are 
degraded in an XRN1-dependent manner which is consistent with findings in yeast (1). Also 
consistent with previous findings, in human cells upon XRN1-KD-mediated transcript 
stabilization, a robust feedback mechanism, which prevents substantial changes in 
abundances of specific mRNAs, was observed suggesting a conserved nature of buffering of 
mRNA abundance in eukaryotes (1). In yeast, Xrn1 has been shown to be localized in the 
nucleus and directly enhances initiation and elongation of transcription by preferentially 
binding to chromatin of transcriptionally active genes (1). It was found that the nuclear 
localization of XRN1 is linked to its exonucleolytic activity; shuttling of other decay factors, 
such as Pat1 and Lsm1 (which were also shown to affect transcription rates), is dependent on 
XRN1 ability to fully degrade mRNA (1). This suggests that XRN1 is a major transcript decay-
checkpoint factor that balances mRNA decay with transcription rates and hence, appears to 
be the master coordinator of this gene expression buffering mechanism. However, it was also 
observed that upon XRN1 depletion, other major decay factors can shuttle in an XRN1-
independent manner and impact transcription rates, suggesting some redundancies in the 
buffering mechanism.  
CNOT6-KD led to destabilization of 5 out of 10 tested transcripts. Consistent with yeast data, 
depletion of CNOT6 did not result in changes in abundance of specific mRNAs which is 
attributed to adjustment of transcription rates to balance changes in decay rates (15). 
Abundance of three mRNAs were regulated by a CNOT6-KD-mediated buffering response, 
suggesting that transcription of different genes can be regulated by different decay factors; 
this specificity could be dependent on primary routes of mRNA decay. These data raise an 
important question: why does depletion of CNOT6, a decay factor which generally initiates 
mRNA decay, result in destabilization of transcripts? CNOT6 is a conserved general 
eukaryotic deadenylase (32) which plays a key role in removal of poly(A) binding protein 
(PABP) exposing the poly(A) tail to Caf1 which degrades PABP-free poly(A) tail (33,34). 
Depletion of CNOT6 may prevent or delay the removal of PABP and subsequent shortening 
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of the poly(A) tail by Caf1 and hence, delay poly(A) tail length dependent decapping. 
Prevention of poly(A) tail length dependent decapping could lead to activation of alternative 
decay pathways, such as poly(A) tail length-independent decapping, which could behave 
more aggressively, including activation of specific 5’-3’ mRNA decay factors; this is consistent 
with mRNA decay pathway redundancy (35). Thus, it is imperative to investigate the state of 
the 5’ and 3’ ends of mRNA in response to CNOT6 KD, as transcript destabilization could be 
a result of an indirect effect of stabilization of other decay factor mRNA. It cannot be ruled out 
that CNOT6 could be functioning primarily in the nucleus (32) as a potential repressor of 
transcription, we observed a dramatic increase in the level of pre-mRNA, enhanced 
transcription in turn could signal to cytoplasmic destabilization to maintain the steady-state 
mRNA level. Future work should aim to investigate CNOT6 targets on a genome-wide scale 
in order to elucidate its effect on stability of different mRNAs in cancerous and non-cancerous 
cells. Consistent with our findings, in mice 24 transcripts were found to be destabilised upon 
depletion of PARN deadenylase (14). It was suggested that this could be due to knock-on 
effects of some PARN-KD mediated stabilized transcripts (e.g. EDC3, the decapping 
enhancer protein 3) or off-target effects of shRNA constructs used to knockdown PARN in 
mice (14), whether or not buffering was active was not investigated for these destabilised 
transcripts. It was not observed whether destabilization of specific transcripts is a result of 
overactive alternative pathways (e.g. overexpression of XRN1); if this is the case, this buffering 
response could solely be attributed to robust XRN1-mediated signalling, as opposed to 
CNOT6 mediated buffering. In yeast, depletion of Ccr4 led to stabilization of transcripts and 
maintenance of steady-state mRNA levels due to adjustment to the rate of transcription (15), 
however it is also not known whether deletion of this deadenylase led to overexpression of 
other mRNA decay factors. Such discrepancies, despite the conserved nature of Ccr4 
throughout all eukaryotes, may in part be due to the cancerous nature of HepG2 cells and a 
genome-wide investigation of the transcriptome of CNOT6-KD should help to clarify this 
phenomenon.  
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Translation is an integral part of gene expression and it was previously proposed that gene 
expression is circular (1), which implies that all stages of this pathway in the cytoplasm can 
signal back to transcription in order to adjust the pattern of expression. Therefore, it was 
important in this study to test the involvement of the translational apparatus in this buffering 
mechanism. We chose the translation release factor ETF1, eukaryotic release factor 1 and 
three out of the ten tested transcripts were destabilized upon ETF1-KD. Surprisingly, the 
destabilized transcripts also displayed an enhanced level of transcription, resembling the 
CNOT6-KD phenotype, such that the level of abundance of these mRNAs was not significantly 
affected. Whilst the translational efficiency of the tested mRNAs in this cell-line was not tested, 
the presented data is consistent with the notion that translation is intimately linked to mRNA 
stability (36). At this stage it is difficult to explain the observed destabilization of certain 
transcripts, although it is feasible that depletion of ETF1, the protein which is involved in the 
recognition of the stop codon, may result in a prolonged “pausing” of the ribosome on the stop 
codon; this pausing, in turn, may trigger a no-go decay pathway (37) or activation of a 
nonsense mediated decay like response which is known to be a global regulator of 
translational fidelity (38-40). Enhanced activity of some specific decay factors, as a potential 
off-target effect of the ETF1-KD, could also play a part. Nevertheless, ETF1-KD-dependent 
alteration of transcript stability activates a buffering response via inverse adjustment of 
transcription rates resembling the CNOT6-KD like phenotype. This argues that ETF1 is 
involved in steady-state buffering and that translation may be intrinsically linked to 
transcription.    
Abundance of CPLX2 and CDKN1A mRNAs was seen to be buffered in both XRN1-KD and 
CNOT6-KD cell-lines, whilst some other transcripts only had a buffering response to 
knockdown of specific factors. Despite the opposite alteration in their stability (stabilization in 
XRN1-KD vs destabilization in CNOT6-KD) the steady-state level of both mRNAs in these 
KDs was maintained. This suggests that mRNA decay factors may play additional roles in 
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degradation, such as coordinating the “optimal” mRNA decay rate, or decay polarity as 
previously shown in yeast and plants (41,42).  
The observed down-regulation of the stability and transcription of CDK6, a key regulator of the 
G1/S cell cycle transition (43), in all three KD derivatives shows that the abundance of some 
transcripts may not be regulated by this buffering mechanism. Instead, expression of these 
genes may be controlled by their effectors such as a cyclin-dependent kinase inhibitor (44) 
the abundance of which is subject to the buffering mechanism, i.e. we found the level of the 
CDKN1A transcript is buffered. This suggests a potential hierarchy in regulation of gene 
expression, which is yet to be fully understood.  
The observed buffering of transcript abundance does not always result in precise maintenance 
of steady-state mRNA levels, such that the abundance of some transcripts is changed upon 
decay/translation factor KD despite inverse-changes in transcription rate. This phenomenon 
has been noted previously in mammals upon PARN-KD (14) and in yeast, in response to 
depletion of Xrn1 (1). Whilst such inaccuracy could be merely due to over active or repressed 
transcription, it is still not clear why for some transcripts the level of expression is maintained 
more accurately than for others, implying the possible existence of different mechanisms of 
regulation of transcription in response to alteration of stability. It also cannot be ruled out that 
such inaccuracy may be due to signalling from changes in the rate of translation. Either of 
these possibilities could hold true, but the finding of the present study, that translation is also 
involved in the buffering mechanism, adds another dimension to the evidence for gene 
expression cross talk. This suggests that translation may also contribute to determination of 
the rate of transcription and degradation, providing the cell with an additional level of protection 
against perturbation in gene expression steps. 
HepG2 is a cancer cell-line and does not represent wild-type cell homeostasis, such that its 
gene expression signature differs from non-cancerous epithelial liver cells (45). Whilst it is 
highly likely that steady-state levels of transcripts would also be buffered in physiological cells 
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by the same buffering mechanism, the patterns of abundance are likely to be different. The 
half-lives of c-FOS and c-MYC mRNAs in HepG2 cells were found to be consistent with those 
previously found in other cancerous cell lines, including HeLa (cervix carcinoma), MCF7 
(breast carcinoma) and Daudi (Burkitt lymphoma) (46,47) and their transcript abundance is 
subject to regulation by XRN1-dependent buffering mechanism. This suggests that expression 
of specific oncogenes during cancers is tightly regulated in order to maintain the cancerous 
phenotype and can involve the buffering mechanism. Hence, elements of the buffering 
mechanism could represent targets for novel therapies for cancer. 
Material and Methods  
Cell culture. The human epithelial hepatocellular carcinoma cell-line HepG2 (HB-8065) was 
obtained from the American Type Culture Collection (ATCC). HepG2 was cultured in high-
glucose Dulbecco’s Modified Eagle’s Media DMEM, supplemented with 10% heat inactivated 
Fetal Bovine Serum (FBS) and 1% penicillin/streptomycin grown in 5% CO2 at 37⁰C as per 
ATCC’s recommendation. The human epithelial embryonic kidney cell line HEK293t (CRL32-
16) was obtained from ATCC. HEK293t was cultured in high-glucose DMEM, supplemented 
with 10% FBS, 2mM L-glutamine, and grown in 5% CO2 at 37⁰C.  
Lentiviral packaging of shRNA plasmids and generation of knockdown strains. 
Transcript knockdown was undertaken using shRNA constructs specific to XRN1, CNOT6 and 
ETF1 transcripts packaged into lentivirus particles (14). Validated shRNA constructs were 
chosen from the Broad Institute’s RNAi consortium (Table S2). Constructs had specific target 
sequences inserted between the AgeI and EcoRI restriction sites of the pLKO.1 plasmid 
(Addgene #10878, a kind gift from David Root) resulting in recombinant plasmids of around 
7.5kb in length. The plasmid constructs were packaged into lentivirus particles using the 
HEK293t cell-line as a host, as previously described (30). The pLJM1-EGFP plasmid 
(Addgene #19319, a kind gift from David Sabatini) was used as a positive control for 
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transfection and transduction.  Transduced cells were selected for using puromycin (3µg/ml). 
Details of shRNA knockdown are provided in Supplementary Materials and Methods. 
Extraction and manipulation of RNA and qRT-PCR. Total RNA was isolated using Trisure 
(Bioline) as per the manufacturer instructions. Briefly, the cell monolayer was washed with ice 
cold PBS and 1ml Trisure reagent was added per 10cm2 surface area. After 5 minutes of 
gentle agitation, the cell lysate was collected and mixed with 0.2ml of chloroform per 1ml 
Trisure. The samples were centrifuged at 12000xg at 4⁰C for 10 minutes. The upper aqueous 
phase was mixed with an equal volume of chloroform, vortexed and centrifuged as previously. 
RNA in the upper phase was precipitated with equal volume of cold isopropanol. The pellet 
was air-dried, washed twice with 70% EtOH and resuspended in 10mM Tris, pH7.4. Total RNA 
was treated with DNase Turbo DNase (Invitrogen) as per manufacturer recommendation. 
To determine half-lives of transcripts, an mRNA stability time-course was undertaken. 
Proliferating cultures were treated with actinomycin D (8µg/ml) for 30 minutes prior to the start 
of time course (14) with time points of T0, 30 minutes, 60 minutes and 120 minutes. Total RNA 
was extracted as described previously.  
RNA samples were reverse transcribed using the Tetro cDNA synthesis kit using N6 random 
hexamer primers (Bioline) as per manufacturer recommendations. The relative expression of 
transcripts was measured by quantitative (q)PCR using Biorad iTaq 2x Supermix and the CFX-
Connect RealTime PCR detection system. Three housekeeping genes were used for 
normalisation: Succinate Dehydrogenase subunit A (SDHA), Glyceraldehyde 3-Phosphate 
Dehydrodenase (GAPDH) and Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase 
Activation protein-Zeta (YWHAZ). Housekeeping genes were chosen by use of the geNorm 
kit by Primer Design, the variance in expression between strains was analysed using qbase+ 
software as per manufactory recommendation. Expression of the three chosen RNA Pol II 
housekeeping genes was normalized to 18S rRNA (RNA Pol I transcript) and no differences 
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in the abundance between each KDs and control cell-lines was observed. Primer sequences 
are listed in Table S1A.  
Metabolic labelling of RNA for measurement of transcription rates. To measure the rate of 
transcription, RNA was metabolically labelled using 4sU and extracted, followed by isolation 
of pre-mRNA using streptavidin magnetic beads as described previously (14). The level of 
pre-mRNA abundance was measured by qRT-PCR using a primer pair with the amplicon 
spanning an intron-exon junction of the target gene. The level of pre-mRNA abundance was 
normalised to that of 7SL rRNA as described previously (14). Primer sequences are listed in 
Table S1B. Details of pre-mRNA isolation are described in Supplementary Materials and 
Methods. 
Protein extraction and Western Blot. Protein extracts were prepared using the detergent 
based cell lysis RIPA buffer (10mM Tris-Cl pH 8.0, 1mM EDTA, 1% Triton X-100, 1% Sodium 
deoxycholate, 0.1% SDS, 140mM NaCl and 1mM protease inhibitor cocktail (Sigma). Western 
blot was undertaken as previously described (14). Primary antibodies are listed in Table S3. 
Detailed protocol is described in Supplementary Materials and Methods. 
Data analysis. The fold changes in abundance, half-life and pre-mRNA between KD cell-lines 
and CTRL cells were determined by qRT-PCR (27). A paired T-test was conducted for each 
ΔCT value for each gene per strain (n≥3) for total and pre-mRNA samples. The P-values for 
half-life analysis were calculated by paired T-tests which were conducted to compare the half-
lives between the CTRL and strain cell lines (n≥3). For determination of half-life, time points 
were fit to a nonlinear least squares model with confidence intervals (R2) >75% and half-lives 
were extrapolated from the decay curve (48). Average half-life curves are presented in 
Supplementary Figure S1. The truncated product method (29) was applied on all P-values in 
this study to determine whether there was bias from testing of multiple hypotheses. The 
truncated product method P-value was <0.0001 which is an indicator that statistically 
significant results were not biased by multiple comparison. The relative level of protein 
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abundance was determined by densitometry analysis using the ImageJ software, protein 
abundance was normalised to that of GAPDH. 
 
During the revision of the manuscript a new publication on the involvement of translation in 
buffering in yeast by Blasco-Moreno et al 2019 (49) has emerged which is consistent with the 
findings of this study.    
 
Acknowledgements. PS was supported by the Health Life Sciences Faculty research Centre 
for Sport, Exercise and Life Sciences, Coventry University. We would like to thank S. Tompsett 
and H. Kikuchi for technical assistance. 











mRNA abundance is buffered in human cells 
 
References 
1. Haimovich G, et al. (2013) Gene expression is circular: factors for mRNA degradation also 
foster mRNA synthesis. Cell 153:1000–1011. 
2. Braun KA, Young ET (2014) Coupling mRNA synthesis and Decay. Mol Cell Biol 34: 4078–
4087. 
3. Bellofatto V, Wilusz J (2011) Transcription and mRNA Stability: Parental Guidance 
Suggested. Cell 147:1438-1439.  
4. Bregman A, et al. (2011) Promoter elements regulate cytoplasmic mRNA decay. Cell 
147:1473–1483.  
5. Trcek T, Larson DR, Moldón A, Query CC, Singer RH (2011) Single-molecule mRNA decay 
measurements reveal promoter regulated mRNA stability in yeast. Cell 23:1484-1497. 
6. Goler-Baron V, et al. (2008) Transcription in the nucleus and mRNA decay in the cytoplasm 
are coupled processes. Genes Dev 22:2022-2027. 
7. Farago M, Nahari T, Hammel C, Cole CN, Choder M (2003) Rpb4p, a Subunit of RNA 
Polymerase II, Mediates mRNA Export during Stress. Mol Biol Cell 14:2744-2755.   
8. Harel-Sharvit L, et al. (2010) RNA polymerase II subunits link transcription and mRNA decay 
to translation. Cell 143:552–563.  
9. Lotan R, et al. (2005) The RNA polymerase II subunit Rpb4p mediates decay of a specific 
class of mRNAs. Gen & Dev 19:3004-3016.  
10. Lotan R, Goler-Baron V, Duek L, Haimovich G, Choder M (2007) The Rpb7p subunit of 
yeast RNA polymerase II plays roles in the two major cytoplasmic mRNA decay mechanisms. 
J Cell Biol 178:1133-43. 
11. Villanyi Z, et al. (2014) The Not5 Subunit of the Ccr4-Not Complex Connects transcription 
and Translation. PLOS Genet 10:1-15. 
12. Anderson JS, Parker R (1998). The 30 to 50 degradation of yeast mRNAs is a general 
mechanism for mRNA turnover that requires the SKI2 DEVH box protein and 30 to 50 
exonucleases of the exosome complex. EMBO J 17:1497–1506. 
mRNA abundance is buffered in human cells 
 
13. Parker R (2012) RNA degradation in Saccharomyces cerevisiae. Genet 191:671-702. 
14. Lee JE, et al. (2012) The PARN Deadenylase Targets a Discrete Set of mRNAs for Decay 
and Regulates Cell Motility in Mouse Myoblasts. PLoS Genet 8:1-13. 
15. Sun M, et al. (2012) Comparative dynamic transcriptome analysis (cDTA) reveals mutual 
feedback between mRNA synthesis and degradation. Genome Res 22:1350-1359. 
16. Sun M, et al. (2013) Global analysis of eukaryotic mRNA degradation reveals Xrn1-
dependent buffering of transcript levels. Mol Cell 52:52–62. 
17. Haimovich G, Choder M, Singer RH, Trcek T (2013) The fate of the messenger is pre-
determined: A new model for regulation of gene expression. BBA 1829:643–653.  
18. Goler-Baron V, et al. (2008) Transcription in the nucleus and mRNA decay in the 
cytoplasm are coupled processes. Gen & Dev 22:2022–2027. 
19. Selitrennik M, Duek L, Lotan R, Choder M (2006) Nucleocytoplasmic Shuttling of the 
Rpb4p and Rpb7p Subunits of Saccharomyces cerevisiae RNA Polymerase II by Two 
Pathways. Eukaryot Cell 5:2092–2103. 
20. Dori-Bachash M, Shalem O, Manor YS, Pilpel Y, Tirosh I (2012) Widespread promoter-
mediated coordination of transcription and mRNA degradation. Gen Biol 13:1-14. 
21. Dori-Bachash M, Shema E, Tirosh I (2011) Coupled Evolution of Transcription and mRNA 
Degradation. PLOS Genet 9:1-13. 
22. Cuenca-Bono B, et al. (2010) A novel link between Sus1 and the cytoplasmic mRNA decay 
machinery suggests a broad role in mRNA metabolism. BMC Cell Biol 11:19. 
23. Kohler A, Hurt E (2007) Exporting RNA from the nucleus to the cytoplasm. Nat Rev Mol 
Cell Biol 8:761-773. 
24. Windgassen M, et al. (2004) Yeast shuttling SR proteins Npl3p, Gbp2p, and Hrb1p are 
part of the translating mRNPs, and Npl3p can function as a translational repressor. Mol Cell 
Biol 24:10479-10491. 
25. Braun JE, Huntzinger E, Fauser M, Izaurralde E (2011) GW182 proteins directly recruit 
cytoplasmic deadenylase complexes to miRNA targets. Mol Cell 44:120–133.  
mRNA abundance is buffered in human cells 
 
26. Sandler H, Kreth J, Timmers HTM, Stoecklin G. (2011) Not1 mediates recruitment of the 
deadenylase Caf1 to mRNAs targeted for degradation by tristetraprolin. Nucleic Acids Res 
39:4373–4386.  
27. Livak KJ, Schmittgen TD (2001) Analysis of Relative Gene Expression Data Using 
RealTime Quantitative PCR and the 2DDCT Method. Methods 25:402–408. 
28. Decker CJ, Parker R (2012) P-bodies and stress granules: possible roles in the control of 
translation and mRNA degradation. Cold Spring Harb Perspect Biol 4:1-16. 
29. Zaykin DV, Zhivotovsky LA, Westfall PH, Weir BS (2002) Truncated product method for 
combining P-values. Genet Epidem 22:170-185. 
30. The Computational Biology and Functional Genomics Laboratory (2012) shRNA Lentivirus 
Production using HEK293T cells and FuGENE. [Online] URL: 
<http://compbio.dfci.harvard.edu/compbio/research/labprotocols/contentBlocks/0/contentBlo
ck_files/file15/Lentivirus_Production_and_Transfection_Protocol.pdf>. 
31. Houseley J, Tollervey D (2009) The many pathways of RNA degradation. Cell 136:763-
776. 
32. Collart MA, Panasenko OO (2012) The Ccr4—not complex. Gene 492:42-53. 
33. Webster MW, et al. (2018) mRNA deadenylation is coupled to translation rates by the 
differential activities of Ccr4-Not nucleases. Mol Cell 70:1089–1100. 
34. Yi H, et al. (2018) PABP cooperates with the CCR4-NOT complex to promote mRNA 
deadenylation and block precocious decay. Mol Cell 70:1081–1088. 
35. Van-Hoof A, Lennertz P, Parker R (2000) Three conserved members of the RNase D 
family have unique and overlapping functions in the processing of 5S, 5.8S, U4, U5, RNase 
MRP and RNase P RNAs in yeast. EMBO J 19:1357–1365. 
36. Inada T, Makino S (2014) Novel Roles of the multi-functional CCR4-NOT complex in post-
transcriptional regulation. Front Genet 5:1-7. 
37. Doma MK, Parker R (2006) Endonucleolytic cleavage of eukaryotic mRNAs with stalls in 
translation elongation. Nature 440:61–564. 
mRNA abundance is buffered in human cells 
 
38. Celik A, He F, Jacobsen A (2017) NMD monitors Translational Fidelity 24/7. Current Genet 
63:1007-1010. 
39. Carnes J, Jacobsen M, Leinwand L, Yarus M (2003) Stop codon suppression via inhibition 
of eRF1 expression. RNA 9:648-653. 
40. Deanna M, Janzen DM, Geballe AP (2004) The effect of eukaryotic release factor 
depletion on translation termination in human cell lines. Nucleic Acids Res 32:4491–4502. 
41. Pilkington GR, Parker R (2007) Pat1 Contains Distinct Functional Domains That Promote 
P-Body Assembly and Activation of Decapping. Mol Cell Biol 28:1298-1312. 
42. Sement F, Ferrier E, Zuber H, Merret R, Gagliardi D (2013) Uridylation Prevents 3' 
Trimming of Oligoadenylated mRNAs. Nucleic Acids Res 41:7115-7127. 
43. Sherr CJ (1994) G1 phase progression: cycling on cue. Cell 79:551–555. 
44. Morgan DO (1995) Principles of CDK regulation. Nature 374:131–134. 
45. Tyakht AV, et al. (2014) RNA-Seq gene expression profiling of HepG2 cells: the influence 
of experimental factors and comparison with liver tissue. BMC Genomics 15:1-9. 
46. Schiavi SC, Belasco JG, Michael E. Greenberg (1992) Regulation of proto-oncogene 
mRNA stability. Biochbnica et Biophysica Acta 1114: 95-106. 
47. Dani C, Blanchard JM, Piechaczyk M, Sabouty SE, Marty L, Jeanteur P (1984) Extreme 
instability of myc mRNA in normal and transformed human cells. Proc. NatI. Acad. Sci. USA 
81: 7046-7050. 
48. Wang Y, et al. (2002) Precision and functional specificity in mRNA decay. Proc. NatI. Acad. 
Sci. USA 99: 5860–5865.  
49. Blasco-Moreno B, et al. (2019) The exonuclease Xrn1 activates transcription and 






mRNA abundance is buffered in human cells 
 
 
Table 1. The half-lives (T1/2) of 10 mRNAs in CTRL cells and upon knockdown of XRN1, 
CNOT6 and ETF1. 
Gene 
ID 

























2353 FOS FBJ Murine 
Osteosarcoma 
Viral Oncogene 
     12±1 58±14 0.0076      4.05            30±5 0.0218 2.03     21±4 0.6072             1.39 




26±6 53±15 0.0043 2.08 26±5 0.4515 1.13 21±6 0.2127 0.85 
3552 IL1A Interleukin 1 35±8 49±10 0.0789 1.34 24±6 0.0396 0.63 46±8 0.0328 1.36 
581 BAX Bcl-2 related 
protein 
44±8 82±22 0.0330 2.44 39±7 0.4860 0.87 
 
  31±10 0.0368 0.71 
1026 CDKN1A Inhibitor of 
CDK2, 4, 6, p21 
49±15 83±25 0.0216 2.18 33±2 0.0238 0.75 22±2 0.0083 0.40 
 




CPLX2 Complexin 2  27±5 94±21 0.0003 3.56 22±1 0.0031 0.65 36±10 0.0846 1.08 
7538 ZFP36 Tristetraproline 35±6 51±2 0.0301 1.84 45±5 0.0191 1.2 75±13 <0.001 2.08 








107±9 78±23 0.0252 0.65 51±13 <0.001 
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Fig. 3.  
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Figure legends.  
Fig.1. Determination the effect of XRN1-KD on the steady-state level of specific transcripts. 
(A) The level of XRN1 protein expression upon shRNA mediated knockdown in CTRL (control) 
and XRN1-KD cell lines. The protein level was determined by western blotting and normalized 
to that of GAPDH and the average percentage of relative expression is shown below each 
lane with the standard deviation derived from three independent experiments. (B) qRT-PCR 
showing the fold change of the Xrn1 transcript in CTRL and XRN1-KD cell lines for 
comparison, error bars indicate deviation from three independent experiments and asterisks 
indicate significant differences (p<0.05). (C) The fold change in mRNA stability for each 
transcript was assessed by normalization of the half-life of mRNA in XRN1-KD to that in CTRL 
cell lines. The half-life of each mRNA was determined by qRT-PCR. (D) The fold change in 
abundance of transcripts following XRN1 depletion was measured by qRT-PCR in XRN1-KD 
and normalised to that in CTRL cell lines. (E) The abundance of newly transcribed pre-mRNAs 
was assessed by qRT-PCR and normalised to the abundance of 7SL RNA. The fold change 
in the pre-mRNA was measured by normalization of the abundance of each pre-mRNA in 
XRN1-KD to that in CTRL cell lines. The error bars in (C), (D) and (E) represent the standard 
error of the mean measured from three independent experiments and three technical repeats 
and asterisks indicate statistically significant differences (p<0.05). 
 
Fig.2. Determination the effect of CNOT6-KD on the steady-state level of specific mRNAs. (A) 
The level of CNOT6 protein and (B) the Cnot6 mRNA expression upon shRNA mediated 
knockdown in CTRL and CNOT6-KD cell lines. Details described as in Fig.1. (C) The fold 
change in transcript stability for each mRNA was measured as describe in Fig.1. (D) The 
abundance of transcripts following CNOT6 depletion was assessed as described in Fig.1. (E) 
The abundance of newly transcribed pre-mRNAs was determined as described in Fig.1. 
 
Fig.3. Determination the effect of ETF1-KD on the steady state level of specific mRNAs. (A) 
The level of ETF1 protein and (B) the Etf1 transcript expression upon shRNA mediated 
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knockdown in CTRL and ETF1-KD cell lines. Details as described in Fig.1. (C) The fold change 
in transcript stability for each mRNA was measured as described in Fig.1. (D) The abundance 
of transcripts following ETF1 depletion was assessed as described in Fig.1. (E) The 
abundance of newly transcribed pre-mRNAs was determined as described in Fig.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
